Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of cdk6 small molecule inhibitors in reducing the resistance of liver cancer cells to antineoplastic drugs or radiotherapy

A technology of small molecule inhibitors and liver cancer cells, which is applied in the field of medicine, can solve problems such as enhanced CDK6 activity, and achieve the effect of improving therapeutic effect and reducing tolerance

Active Publication Date: 2020-06-19
深圳市安帝宝科技有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It has been found that a variety of tumors have CDK6 gene amplification, overexpression, or lack of cell cycle inhibitors, enhanced CDK6 activity caused by mutations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of cdk6 small molecule inhibitors in reducing the resistance of liver cancer cells to antineoplastic drugs or radiotherapy
  • Application of cdk6 small molecule inhibitors in reducing the resistance of liver cancer cells to antineoplastic drugs or radiotherapy
  • Application of cdk6 small molecule inhibitors in reducing the resistance of liver cancer cells to antineoplastic drugs or radiotherapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Example 1 Western blotting method to detect the tolerance of liver cancer cells to 5FU and CIS

[0024] It is believed that the culture method of serum-free medium enhances the drug resistance of chemotherapy drugs 5FU and CIS of liver cancer cells by immunoblotting method, which is positively correlated with the expression of CDK6;

[0025] Spheroid culture method (serum-free medium culture method): Hepatoma cells were inoculated in a low-adhesion 6-well culture plate, and treated with EGF (20ng / ml), bFGF (20ng / ml), B27, LIF (leukemia inhibitory factor, 10ng / ml), 2mmol / L L-glutamine and 40U / ml heparin in DMEM-F12 medium (SFM), cultivated in a 37°C, 5% CO2 incubator for 7 to 10 days.

[0026] Adhesive culture method (serum-free medium culture method): Inoculate liver cancer cells in low-adhesion 6-well culture plates, culture in 37°C, 5% CO2 incubators with DMEM medium containing 10% FBS.

[0027] CCK8 detects the toxic effect of cells on chemotherapeutic drugs 5FU and...

Embodiment 2

[0030] Example 2 CDK6 expression in liver cancer tissues at different advanced stages

[0031] Immunohistochemical analysis of CDK6 expression in liver cancer tissues at different advanced stages showed that CDK6 expression may be positively correlated with liver cancer progression, indicating that CDK6 immunohistochemical method can be used as an indicator of drug resistance in liver cancer. If the expression of CDK6 gene is high in patients with liver cancer, it may indicate that the chemotherapy effect is not good, and targeted drugs CDK4 / CDK6 inhibitors can be used to enhance the therapeutic effect.

[0032] Immunohistochemistry: Paraffin-embedded sections of 30 cases of liver cancer tissues of different advanced stages and 10 cases of normal liver tissues were used for tissue chip construction. Each sample on the chip has a diameter of 0.6mm and a spacing of 0.1mm. After the tissue chip was dewaxed and hydrated by gradient, endogenous peroxidase was blocked with 0.3% hyd...

Embodiment 3

[0034] Example 3 High expression of CDK6 promotes resistance to chemotherapy drugs 5FU and CIS in liver cancer cells

[0035] 3.1 Construction of liver cancer cell lines with high expression of CDK6 gene: including packaging and preparation of virus with high expression of CDK6 gene and screening of liver cancer cell lines with high expression of CDK6 gene.

[0036] 3.2 Packaging and preparation of CDK6 gene high-expression lentivirus: construct the related lentivirus expression vector (pLVX-Puro-CDK6), put 293T packaging cells in a 60mm culture dish before transfection, and inoculate 1-2×10 6 , Transfection can only be carried out when the cell adherent growth density reaches about 80%. The recombinant lentiviral vector, pMD-G, and pPax2 vectors were co-transfected into 293T packaging cells by liposome-mediated method, the plasmid ratio was 8:5:3, and the total amount was 6 μg. Place the transfected 293T cells in 5% CO 2 , 37 ° C incubator culture. After 48 hours and 72 ho...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an application of a CDK6 small molecule inhibitor in reducing liver cancer cell resistance to anti-cancer drugs or radiotherapy or radiotherapy, and belongs to the field of medicine. In the prior art, liver cancer, especially advanced liver cancer, is highly resistant to anti-tumor medicine, based on this, the invention discloses an application of a CDK6 small molecule inhibitor in reducing liver cancer cell resistance to anti-cancer drugs or radiotherapy or radiotherapy. According to the invention, the resistance of the liver cancer cell against the anti-tumor medicament is in positive correlation with the expression of the CDK6, and the CDK6 small molecule inhibitor can obviously reduce the CDK6 expression level of the liver cancer cell, and is suitable for livercancer cells with different types and liver cancer cells in different development stages. Furthermore, the CDK6 can be combined with common anti-tumor medicine for the treatment of liver cancer, thereby greatly improving the therapeutic effect of the medicine and the survival rate of a patient.

Description

technical field [0001] The invention relates to the medical application of a drug, in particular to the application of a CDK6 small molecule inhibitor in reducing the resistance of liver cancer cells to antitumor drugs or radiotherapy, and belongs to the field of medicine. Background technique [0002] Primary hepatocellular carcinoma (hepatocellular carcinoma, HCC) is a malignant tumor with a very high degree of malignancy and a very poor prognosis. At present, the incidence of liver cancer ranks third in China, and the prevention and control of liver cancer is very serious. Progress in the diagnosis, treatment and prognosis of liver cancer is very limited, mainly due to the limited knowledge of the exact molecular mechanisms of the occurrence and development of these tumors, making it difficult to design targeted programs. [0003] The clinical curative effect of liver cancer is not good, and the multidrug resistance of liver cancer cells is often displayed. In the past ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K45/06A61K31/506A61K31/513A61P35/00
CPCA61K31/506A61K31/513A61K45/06A61P35/00A61K2300/00
Inventor 陈家杰吉坤美常港蔡楠
Owner 深圳市安帝宝科技有限公司